Publications

  1. Zheng S, et al. Integrating cullin2-RING E3 ligase as a potential biomarker for glioblastoma multiforme prognosis and radiosensitivity profiling. Radiother Oncol. 2021 Jan;154:36-44
  2. Zheng S, et al. Inhibition of the NEDD8 conjugation pathway induces calcium-dependent compensatory activation of the pro-survival MEK/ERK pathway in acute lymphoblastic leukemia. Oncotarget. 2017 Dec 31;9(5):5529-5544.
  3. Leclerc GM*, Zheng S*, et al. The NEDD8-activating enzyme inhibitor pevonedistat activates the eIF2α and mTOR pathways inducing UPR-mediated cell death in acute lymphoblastic leukemia. Leuk Res. 2016 Nov;50:1-10. (*co-first authors)
  4. Ao Z, et al. Identification of Cancer-Associated Fibroblasts in Circulating Blood from Patients with Metastatic Breast Cancer. Cancer Res. 2015 Nov 15;75(22):4681-7.
  5. Ao Z, et al. Thermoresponsive release of viable microfiltrated Circulating Tumor Cells (CTCs) for precision medicine applications. Lab Chip. 2015 Nov 21;15(22):4277-82.
  6. Jin K, et al. Acetylation of Mastermind-like 1 by p300 Drives the Recruitment of NACK to Initiate Notch-Dependent Transcription. Cancer Res. 2017 Aug 15;77(16):4228-4237.
  7. Wang Z, Da Silva TG, Jin K, et al.  Notch signaling drives stemness and tumorigenicity of esophageal adenocarcinoma. Cancer Res. 2014 Nov 1;74(21):6364-74.
  8. Meng Y, et al. GATA6 phosphorylation by Erk1/2 propels exit from pluripotency and commitment to primitive endoderm. Dev Biol. 2018 Apr 1;436(1):55-65.
  9. Chen L1, Xiao Z, Meng Y, et al. The enhancement of cancer stem cell properties of MCF-7 cells in 3D collagen scaffolds for modeling of cancer and anti-cancer drugs. Biomaterials. 2012 Feb;33(5):1437-44.